Hosting Call at 5:00 pm
ET on Thursday, May 25th
European Q&A Session on May 26th at
8:30am ET
CALGARY,
AB, May 18, 2023 /CNW/ - Nanalysis Scientific
Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA:
1N1), a leader in portable NMR machines and MRI technology for
industrial and research applications announces that
on Thursday, May 25th, 2023, the Company will put out a press
release and Chief Executive Officer Sean
Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at
5:00 P.M. Eastern Time to discuss the
results for the quarter ending March
31, 2023.
Investors interested in participating in the live full year call
can dial 1-888-664-6392 or 416-764-8659 from abroad. Investors can
also access the call online through a listen-only webcast here:
https://app.webinar.net/aJQmbEZXR2l or on the investor relations
section of the Company's website HERE.
The webcast will be archived on the Company's investor relations
webpage for at least 90 days and a telephonic playback will be
available for seven days after the conference call by calling
1-888-390-0541 or 416-764-8677, conference ID #648443.
Additionally, the Company will be hosting a Q&A session for
it's European investors at 8:30am ET on
Friday, May 26th which can be accessed by the following
link: Click here to join the meeting or call in (audio
only) +1 437-703-4522, Phone Conference ID: 967 292 728#
About Nanalysis Scientific
Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis' business is what we term "MRI and NMR for industry".
The Company develops and manufactures portable Nuclear Magnetic
Resonance (NMR) spectrometers or analyzers for laboratory and
industrial markets. The NMReady-60™ was the first full-feature
portable NMR spectrometer in a single compact enclosure requiring
no liquid helium or any other cryogens. The company has followed-up
that initial offering with new products and continues to have a
strong innovation pipeline. In 2020 Nanalysis announced the launch
of its100MHz device, the most powerful and most advanced compact
NMR device ever brought to market.
Nanalysis' devices are used in many industries (oil and gas,
chemical, mining, pharma, biotech, flavor and fragrances,
agrochemicals, law enforcement, and more) as well as numerous
government and university research labs around the world. The
Company continues to exploit new global market opportunities
independently and with partners.
In 2022 the Company acquired K'(Prime) Technologies Inc.
(K'Prime), a North American sales and service company which
provides sales services for scientific instrumentation for pharma,
food, chemical and oil & gas customers, as well as imaging
systems for security applications. K'Prime's service organization
provides airport and commercial security installation and
maintenance solutions across North
America.
Additionally in 2022, the Company acquired a 43% ownership in
Quad Systems AG ("Quad Systems"), a Zurich-based Nuclear
Magnetic Resonance (NMR) company focused on high-field NMR for
pharmaceutical and other vertical markets.
Notice regarding Forward Looking
Statements and Legal Disclaimer
This news release contains certain "forward-looking statements"
within the meaning of such statements under applicable securities
law. Forward-looking statements are frequently characterized by
words such as "anticipates", "plan", "continue", "expect",
"project", "intend", "believe", "anticipate", "estimate", "may",
"will", "potential", "proposed", "positioned" and other similar
words, or statements that certain events or conditions "may" or
"will" occur. These statements are only predictions. Various
assumptions were used in drawing the conclusions or making the
projections contained in the forward-looking statements throughout
this news release. Forward-looking statements are based on the
opinions and estimates of management at the date the statements are
made and are subject to a variety of risks and uncertainties and
other factors that could cause actual events or results to differ
materially from those projected in the forward-looking statements.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services
Provider accepts responsibility for the adequacy or accuracy of
this release.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-first-quarter-2023-conference-call-301828434.html
SOURCE Nanalysis Scientific Corp.